key: cord-0789104-50k9v3vf
authors: Jayawardena, Ranil; Jeyakumar, Dhanushya T.; Francis, Tormalli V.; Misra, Anoop
title: Impact of the vitamin D deficiency on COVID-19 infection and morality in Asian countries
date: 2021-03-13
journal: Diabetes Metab Syndr
DOI: 10.1016/j.dsx.2021.03.006
sha: 4084d2dc77cb1b445a402c5f13d29dd100d3a5a9
doc_id: 789104
cord_uid: 50k9v3vf

BACKGROUND AND AIMS: COVID-19 is a pandemic that has affected beyond 100 million and caused nearly 3 million deaths globally. Vitamin D is a known risk factor for COVID-19. Therefore, we aimed to investigate the association of prevalence of vitamin D deficiency and mean vitamin D level with COVID-19 infection and mortality in Asia, predicting with other confounding factors such as median age, obesity, and diabetes. METHODS: COVID-19 infections and mortalities among the Asian countries were retrieved from the Worldometer website. Information on prevalence of vitamin D deficiency and mean vitamin D values in each Asian country was retrieved through literature searching on PubMed® and Google scholar. The associations between COVID-19 infections and mortalities with prevalence of vitamin D deficiency and mean vitamin D level were explored with correlation coefficients. As a predictive analysis, multiple linear regression was carried out with all confounders. RESULTS: Positive correlations were observed for prevalence of vitamin D deficiency with COVID-19 infections (r = 0.55; p = 0.01; R(2) = 0.31) and mortalities (r = 0.50; p = 0.01; R(2) = 0.25). Moreover, the associations for the COVID-19 infections and mortalities improved to r = 0.76 (p = 0.002; R(2) = 0.58) and r = 0.65 (p = 0.03; R(2) = 0.42) respectively after predicting with confounding factors. Similarly, mean vitamin D level had a significant negative correlation with COVID-19 infections (r = −0.77; p = 0.04; R(2) = 0.59) and mortalities (r = −0.80; p = 0.03; R(2) = 0.63) when combining with confounders. CONCLUSION: Prevalence of vitamin D deficiency is significantly positively associated whereas the mean vitamin D level is significantly negatively associated with both infection and mortality rate of COVID-19 among Asian countries upon predicting with all confounders.

The coronavirus disease (COVID-19) outbreak has rapidly extended globally reaching 51 through to almost every country. The current COVID-19 infections and mortalities are at a 52 staggering number of more than 100 million and nearly 3 million respectively across the 53 world [1] . COVID-19 pandemic has emerged as a public health crisis globally testing the 54 resilience of the health systems and it has been established that severity of the cases as well 55 as the mortality is linked with underlying health conditions [2] . Determining the associated patients [21] . A review studying serum VD concentration with incidence/severity of COVID-101 19 showed that they are inversely correlated [22] . Therefore, VDD showed an increase in 102 thrombotic episodes which were observed frequently in COVID-19 patients, mostly with 103 obese and diabetic individuals [23] .

The association between the severity and mortality of COVID-19 with VDD is 105 distinct. On the whole, VD could act as an important risk factor for COVID-19 severity. 106 Therefore, to further explore the association of VDD and COVID-19 in countries that belong 107 to the Asia. This includes the multiple variants present across all countries; we aimed to 108 investigate the country specific prevalence of VDD as well as mean VD with COVID-19 109 infection and mortality rates in Asia, predicting with other confounders such as median age, 110 prevalence of obesity and diabetes. searched by using the key words, such as "Vitamin D" or "25-hydroxyvitamin D 3 ", combined 124 with "deficiency", "prevalence" or "status" and the name of each Asian country. Additional Lebanon, Oman, Iraq and Turkey were positioned far away from the regression line and the 228 correlation changed to r=-0.41, when they were omitted in the analysis (p=0.22; R 2 =0.17). Table 3 , when the other confounders -median age of the population, (Figure 3b) . 243 With respect to COVID-19 mortality rate, as depicted in Table 3 , upon the addition 244 of median age of the population to the predictive model, the correlation improved from 245 r=0.50 (p=0.01; R 2 =0.25) to r=0.52 (p=0.04; R 2 =0.27) for the VDD prevalence and from r=- 

Results of this study showcased that VDD and mean VD levels of the Asian countries 317 have an association towards the incidence and mortality of the novel coronavirus disease.

People who are deficient in VD may receive daily or weekly supplementation as it is studied 319 to protect against acute respiratory tract infections [20] . Thus, the population at higher risk of 320 VDD during this global pandemic should consider taking VD supplements to maintain the 321 circulating 25(OH)D in optimal levels (75-125 nmol/l) [19] . On that account it shows that VD 322 is a possible protective effect in reducing the infectivity and mortality of COVID-19. to older adults covering a wider pool but high risk of COVID-19 is seen in older adults. 328 Consequently, studying only older adults would have been better. Obesity and DM 329 prevalence data were extracted from WHO databases which is accurate but may be out-dated. 330 Ideally prevalence data for each country would be more precise if searched for each country 331 individually. Obesity cut off values may differ from this database (BMI<30 kgm 2 ) when 332 focused on Asia as the cut off value would be lower due to the different body composition 

COVID-19, 398 SARS and MERS: are they closely related?

Outcomes of COVID-19: disparities in 400 obesity and by ethnicity/race

COVID-19: a systematic Review and Meta-analysis

EClinicalMedicine 2020

Epidemic 405 obesity and type 2 diabetes in Asia

Pandemic 407 Preparedness and Response to COVID-19 in South Asian Countries

COVID-19 and older people in Asia: Asian Working Group for Sarcopenia calls to 411 action

Author, Year Sample size (M/ F) J o u r n a l P r e -p r o o f